These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 18340564)
1. Disposition and metabolism of the colchicine derivative [14C]-ZD6126 in rat and dog. Partridge EA; D'Souza RA; Lenz EM; Smith SM; Clarkson-Jones J; Roberts DW Xenobiotica; 2008 Apr; 38(4):399-421. PubMed ID: 18340564 [TBL] [Abstract][Full Text] [Related]
2. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
3. Distribution of radioactivity and metabolite profiling in tumour and plasma following intravenous administration of a colchicine derivative (14C-ZD6126) to tumour-bearing mice. D'Souza RA; Partridge EA; Roberts DW; Ashton S; Ryan A; Patterson AB; Wilson Z; Thurrell CC Xenobiotica; 2007 Mar; 37(3):328-40. PubMed ID: 17624029 [TBL] [Abstract][Full Text] [Related]
4. Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human. Waters NJ; Smith SA; Olhava EJ; Duncan KW; Burton RD; O'Neill J; Rodrigue ME; Pollock RM; Moyer MP; Chesworth R Cancer Chemother Pharmacol; 2016 Jan; 77(1):43-62. PubMed ID: 26645404 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs. Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing. Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853 [TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease. Azuma R; Komuro M; Korsch BH; Andre JC; Onnagawa O; Black SR; Mathews JM Xenobiotica; 1999 Jul; 29(7):747-62. PubMed ID: 10456692 [TBL] [Abstract][Full Text] [Related]
12. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
13. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite. Paul H; Illing A; House ES Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331 [TBL] [Abstract][Full Text] [Related]
14. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways. Dalvie DK; Khosla NB; Navetta KA; Brighty KE Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858 [TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog. Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109 [TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism and mass balance of 4-[4-fluorophenoxy]benzaldehyde semicarbazone in rats. Ramu K; Lam GN; Hughes H Drug Metab Dispos; 2000 Oct; 28(10):1153-61. PubMed ID: 10997933 [TBL] [Abstract][Full Text] [Related]
17. Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man. McKillop D; Hutchison M; Partridge EA; Bushby N; Cooper CM; Clarkson-Jones JA; Herron W; Swaisland HC Xenobiotica; 2004 Oct; 34(10):917-34. PubMed ID: 15764411 [TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549 [TBL] [Abstract][Full Text] [Related]
19. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat. Lee J; Son J; Rhee SW; Kim DH Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]